search icon
  • Print
  • ShareThis
  • Text Size
  • Hepatitis C Virus

    Bringing Expert Clinical Guidance to a Rapidly Changing Field

    • HCV Webinar Logo

      IDSA Knowledge Network Webinar Series

      A series of monthly, hour-long webinars for IDSA members on current recommended practices to effectively identify, treat, and manage patients infected with the hepatitis C virus.


      >> Log in to watch the webinars
    • HCV Guideline

      Expert Guidance on Treatment

      Up-to-date guidance for the treatment of HCV infection from IDSA and the American Association for the Study of Liver Diseases, in collaboration with the International Antiviral Society-USA.


    • HCV MOC

      Maintenance of Certification

      IDSA offers a Maintenance of Certification module specific to Hepatitis C.


      >> Read more about IDSA MOC modules

    Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.


    HCV: Clinical Recommendations


    Up-to-date guidance for the treatment of HCV infection from IDSA and the AASLD. >> Go to

    share your story

    Get Tested

    The U.S. Preventive Services Task Force (USPSTF) recommends screening for HCV infection to adults born between 1945-1965. Read the full report >>


    Find Treatment

    State-by-state information for hepatitis C patients >>

  • Clinical Guidance (3)
    Educational Resources (5)
    • IDSA HCV Knowledge Network

      The IDSA Hepatitis C (HCV) Knowledge Network offers a monthly, hour-long webinar to educate IDSA members about the current recommended practices to effectively identify, treat, and manage patients infected with the hepatitis C virus (HCV).
    • Hepatitis C Curriculum for Clinicians


    • HCV Treatment Options - Video

      Presented at IDWeek 2012, this video teaches how to discuss the benefits and risks of new HCV therapies to various patient populations, explain the treatment success/failure rates, analyze the therapy costs and insurance challenges, and develop a working knowledge of the practice infrastructure necessary to treat these patients.
    • HCV - Continuing Medical Education

      IDSA has compiled a list of HCV-related CME opportunities.
    • HCV Research Resources

      Resources from the Annals of Internal Medicine, the US Department of Health and Human Services, and others on the latest in hepatitis C research.
    Management of Hepatitis C (5)
    • AASLD Guideline: Management of Hepatocellular Carcinoma (PDF)

      AASLD's 2005 guidelines have been updated to include new information about the management of hepatocelluar carcinoma.
    • Management and Treatment of Patients with Cirrhosis and Portal Hypertension Review (PDF)

      Recommendations from the Department of Veterans Affairs to manage and treat cirrhosis and portal hypertension based on evidence in literature, including randomized clinical trials and met-analyses.
    • HCV Management - Additional Information

      Additional hepatitis C management resources from the Department of Veterans Affairs, the Forum for Collaborative HIV Research, and others.
    • HCV Screening Letter

      IDSA encourages Society members to reach out to their primary care partners in support of the USPSTF's recent recommendations on HCV screening.
    • HCV Rx Appeal Letter Template

      In response to action taken by some State Medicaid programs to restrict the specialties of providers who can prescribe drug therapies to treat hepatitis C virus (HCV), IDSA has developed an appeals letter template recommending that Infectious Diseases (ID) Specialists and other HIV providers be covered prescribers of all HCV medications. The letter provides succinct evidence points as well as a link to the appeals letter sent to the Center for Medicare and Medicaid Services (CMS).
    Primary Care Resources (3)
    Quality Improvement (1)

    | HIVMA | Contact Us

    © Copyright IDSA 2017 Infectious Diseases Society of America

    Full Site Mobile Site